Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06704334

The Study of Ginkgo Leaf Dropping Pills and Huperzine a Injection Combined with Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain Injury

This study will conduct a single-center clinical trial to explore the initial therapeutic effect of ginkgo biloba dropping pills, huperzine A injection and median nerve electrical stimulation in patients with cognitive impairment.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

The Ganzhou City People's Hospital

Ganzhou, Jiangxi, 8112320, China

Location status: Recruiting

Location contact

Dong Wang

CONTACT

[email protected]

18007076858

Dong Wang

CONTACT

About this study

Specific experimental research methods were randomized, controlled, single-center, exploratory clinical study, through the treatment of ginkgo biloba dropping pills, huperzine A injection and median nerve electrical stimulation in patients with cognitive impairment, to observe the effects of their neuroprotection and cognitive function improvement.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be over 18 years old
  • Residual cognitive impairment due to brain injury
  • No previous history of brain-related diseases except this one

Exclusion criteria

  • The patient had severe underlying disease and unstable vital signs
  • The patient was complicated with consciousness disorder and could not cooperate with cognitive function assessment ③ Allergic to drugs or contraindications in drug use ④ There are contraindications of median nerve electrical stimulation

Treatment and study plan

Median nerve electrical stimulation treatment

Other

Median nerve electrical stimulation is an electrical stimulation therapy in which the electrode is placed at the median nerve point 2cm above the carpal wrinkles on the palmar surface of the wrist joint. Generally, the right median nerve is used for electrical stimulation. Electrical stimulation improves cognitive function by stimulating neurons in the brain and improving information transmission between neurons. When electrical current stimulates the brain, it can increase the activity level of neurons and promote the signal transmission between neurons. Its mechanism of action includes the regulation of neurotransmitter acetylcholine, thereby enhancing cognitive function.

Huperzine A injection

Drug

intramuscular

Ginkgo leaf dropping pill

Drug

oral

Primary outcomes

  1. to assess the MMSE score

    Time frame: baseline,Day10,Day90

Secondary outcomes

  1. to assess the MoCA score

    Time frame: baseline,Day10,Day90

  2. to assess the ADAS-cog score

    Time frame: baseline,Day10,Day90

  3. to assess the HAMD score

    Time frame: baseline,Day10,Day90

  4. to assess the HAMA score

    Time frame: baseline,Day10,Day90

Study contacts

Contact information is provided by the study sponsor or research team.

Dong Wang

CONTACT

[email protected]

18007076858

Sponsors and collaborators

Lead sponsor

Wanbangde Pharmaceutical Group Co., LTD

Industry

Collaborators

  • Ganzhou City People's Hospital

Registry information

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Nov 26, 2024
Registry last updated
Dec 11, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.